Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

West Nile Virus Infections - Pipeline Review, H2 2013 - New Market Research Report


Print article Print article
2013-12-19 12:41:12 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'West Nile Virus Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for West Nile Virus Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for West Nile Virus Infections. West Nile Virus Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- www.fastmr.com/prod/755156_west_nile_virus_infections_pipeline_r ..

Note*: Certain sections in the report may be

removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for West Nile Virus Infections.
* A review of the West Nile Virus Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the West Nile Virus Infections pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for West Nile Virus Infections.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding West Nile Virus Infections pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned in this Report: CEL-SCI Corporation, Hemispherx Biopharma, Inc., Kineta, Inc., Hawaii Biotech, Inc.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
West Nile Virus Infections Overview
Therapeutics Development
An Overview of Pipeline Products for West Nile Virus Infections
West Nile Virus Infections Therapeutics under Development by Companies
West Nile Virus Infections Therapeutics under Investigation by Universities/Institutes
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
West Nile Virus Infections Therapeutics - Products under Development by Companies
West Nile Virus Infections Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in West Nile Virus Infections Therapeutics Development
CEL-SCI Corporation
Hemispherx Biopharma, Inc.
Kineta, Inc.
Hawaii Biotech, Inc.
West Nile Virus Infections - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
CEL-1000 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HBV-002 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Innate Immune Agonists - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VG-WNV - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BG-323 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Antibody Against West Nile Virus - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Plant Derived Hu-E16 Monoclonal Antibody - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drugs for Dengue Virus and West Nile virus - Drug Profile
Product Description
Mechanism of Action
R&D Progress
West Nile Virus Infections Therapeutics - Drug Profile Updates
West Nile Virus Infections Therapeutics - Dormant Products
West Nile Virus Infections - Product Development Milestones
Featured News & Press Releases
Sep 12, 2013: Hemispherx Announces Initial Test Results in Biosecurity/Biodefense Arena
Sep 06, 2011: Hemispherx Enters Into Strategic Alliance With Armada Health Care For Alferon N Injection
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for West Nile Virus Infections, H2 2013
Products under Development for West Nile Virus Infections - Comparative Analysis, H2 2013
Number of Products under Development by Companies, H2 2013
Number of Products under Investigation by Universities/Institutes, H2 2013
Comparative Analysis by Early Clinical Stage Development, H2 2013
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013
Products under Development by Companies, H2 2013
Products under Investigation by Universities/Institutes, H2 2013
CEL-SCI Corporation, H2 2013
Hemispherx Biopharma, Inc., H2 2013
Kineta, Inc., H2 2013
Hawaii Biotech, Inc., H2 2013
Assessment by Monotherapy Products, H2 2013
Assessment by Stage and Route of Administration, H2 2013

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=755156&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser